Jasper Therapeutics inks $35 mln Series A

Jasper Therapeutics Inc, a new biotechnology company, has secured $35 million in Series A financing.

Jasper Therapeutics Inc, a new biotechnology company, has secured $35 million in Series A financing. Abingworth LLP and Qiming Venture Partners USA were the lead investors.

Source: Press Release